This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

II. Human Studies with Particular Reference to Evaluation of Renal Function

ELLARD M. YOW, M.D.; JOHN H. MOYER, M.D.

AMA Arch Intern Med. 1953;92(2):248-257.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AS THE use of anitbiotics has become more widespread, there has been an - increasing number of strains of bacteria resistant to the most commonly used antimicrobial agents. Among the Gram-positive cocci, the Staphylococcus has shown the most rapid development of resistance. Pseudomonas aeruginosa and the Proteus group of Gram-negative bacilli are frequently naturally resistant to most of the antibiotics, and they rapidly acquire resistance to streptomycin. There has also been encountered an increasing number of strains of the coli-aerogenes group resistant to the usual antibiotics. In spite of the reported undesirable side reactions associated with polymyxin therapy, there have now been many clinical reports of patients having been treated successfully with polymyxin when other agents have failed. Its effect has been most striking in infections due to Ps. aeruginosa.¹ Polymyxin has also been of value in the treatment of acute and chronic Shigella infection resistant to previous therapy² . . . [Full Text PDF of this Article]

Author Affiliations
With the Technical Assistance of Miss C. Polk Smith HOUSTON, TEXAS

From the Departments of Medicine and Pharmacology, Baylor University College of Medicine, the Ben Taub Infectious Disease Laboratory and the Cardiac Clinic, Jefferson Davis Hospital.

Footnotes
This study was supported in part by a grant from Burroughs, Wellcome & Company, Inc., and the polymyxin B (Aerosporin) was supplied through the courtesy of Dr. Donald S. Searle, Medical Director, Burroughs, Wellcome & Company, Inc.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?